• Mashup Score: 0

    England’s first Rare Diseases Action Plan, published on Feb 28 to mark Rare Disease Day 2022, was met with a mixture of hope and apprehension. Hope that the many people who suffer from individual rare diseases will benefit from faster diagnosis and increased support, but apprehension that much of what is promised will be a struggle to deliver given the strained resources of the National Health…

    Tweet Tweets with this article
    • "People with rare diseases rightly deserve to find themselves at the top of the health-care agenda for a change" In our April editorial we discuss England's first Rare Diseases Action Plan https://t.co/nwAJM8L42k #LancetRheumatology https://t.co/C1ZZpQhdvk

  • Mashup Score: 3

    Explore clinical research, expert reviews, and comment and opinion from The Lancet Rheumatology. A voice for rheumatology specialists worldwide

    Tweet Tweets with this article
    • Our April issue is live! Including #PsoriaticArthritis, Systemic #lupus erythematosus, #COVID19 outcomes in #gout, plus much more! Follow #LancetRheumatology https://t.co/XGoKvOj8eO https://t.co/vHWmvjgrvw

  • Mashup Score: 0

    Explore clinical research, expert reviews, and comment and opinion from The Lancet Rheumatology. A voice for rheumatology specialists worldwide

    Tweet Tweets with this article
    • Our April issue is live! Including #PsoriaticArthritis, Systemic #lupus erythematosus, #COVID19 outcomes in #gout, plus much more! Follow #LancetRheumatology https://t.co/XGoKvOj8eO https://t.co/SRdwzVPm5h

  • Mashup Score: 0
    Research in Brief - 2 year(s) ago

    Tofacitinib did not demonstrate non-inferiority to TNF inhibitors on the coprimary outcomes of major cardiovascular events (MACE) and cancer (excluding non-melanoma skin cancer) in patients with rheumatoid arthritis and elevated cardiovascular risk in the open-label, non-inferiority, ORAL Surveillance trial by Steven Ytterberg and colleagues. 4362 patients aged 50 years or older with active…

    Tweet Tweets with this article
    • March Research in Brief featuring #PsoriaticArthritis, #JIA, #fibromyalgia, and more! https://t.co/46Ec6SYHp4 #LancetRheumatology https://t.co/2Ck1idBiCy

  • Mashup Score: 10
    Battling burnout - 2 year(s) ago

    The future of global health care is at risk. The pandemic, along with overwhelming workloads and record waiting lists, has exacerbated existing barriers to ensuring the wellbeing of health-care workers, leading to fatigue, stress, and poor mental health. As a result, health-care workers are leaving their jobs in droves, citing exhaustion and burnout. What will it take to avert further crisis?

    Tweet Tweets with this article
    • Battling burnout—In our March editorial we discuss the global crisis of burnout in health-care workers https://t.co/xguJYYpMjf #LancetRheumatology https://t.co/uXu21jVRcQ